Back to Search
Start Over
Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases.
- Source :
-
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2021 Jan; Vol. 31 (1), pp. 139-143. Date of Electronic Publication: 2020 Sep 30. - Publication Year :
- 2021
-
Abstract
- Competing Interests: Competing interests: AMO is on the steering committee of GlaxoSmithKline, AstraZeneca, Clovis, Tesaro and Merck (uncompensated), and is PI on clinical trials for AstraZeneca, GlaxoSmithKline, and Clovis.
- Subjects :
- Brain Neoplasms diagnostic imaging
Brain Neoplasms pathology
Cystadenocarcinoma, Serous surgery
Female
Humans
Magnetic Resonance Imaging
Middle Aged
Ovarian Neoplasms genetics
Ovarian Neoplasms pathology
Ovarian Neoplasms surgery
Brain Neoplasms secondary
Cystadenocarcinoma, Serous drug therapy
Ovarian Neoplasms drug therapy
Phthalazines administration & dosage
Piperazines administration & dosage
Poly(ADP-ribose) Polymerase Inhibitors administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1525-1438
- Volume :
- 31
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
- Publication Type :
- Academic Journal
- Accession number :
- 32998861
- Full Text :
- https://doi.org/10.1136/ijgc-2020-001849